Investment case

INVESTORS RELATIONS

scroll

Why invest in Accrol Group Holdings plc?

  • Accrol is the market leader in the fastest growing segment of UK consumer soft tissue market, private label (also known as own label).
  • Private label sales represent circa 52% of the £1.8bn UK tissue market.
  • Market is growing by over 8% year on year and sales in traditional big brands are declining by circa 6% year on year.
  • Accrol has an industry leading product range and a broad customer base – no one customer represents more than 20% of revenue.
  • The UK soft tissue market is consolidating, improving the opportunity and returns for the strongest players.
  • The Group is highly cash generative.
  • Accrol has a highly experienced and invested management team with proven track record in transformational change, operational excellence and commercial leadership that delivers consistent levels of return.
  • Accrol has a keen understanding of consumer behaviour, enabling the Group to react quickly to and capitalise on changing trends.
  • A relentless drive on operational efficiency and input cost management has created the strongest foundations on which to grow.
  • The business has been fully restructured and is now well invested and operationally efficient with significant headroom for growth.

MARKET WORTH £1.8BN

PRIVATE LABEL GROWS AT 8% PER YEAR

ACCROL HAS 29% OF THIS MARKET AND GROWING

MARKET WORTH £1.8BN

PRIVATE LABEL GROWS AT 8% PER YEAR

ACCROL HAS 29% OF THIS MARKET AND GROWING

Dan Wright - Investment Case